On-demand education

WHO 2022 Classification of Male Genitourinary Tract tumor: What is relevant? Novelties for the practicing urologist?

Dr. Richard Cathomas about Immunotherapy in muscle-invasive bladder cancer

New insights in treatment of bladder cancer: From localised to metastatic diseases

Artificial intelligence: The role for research and patient treatment

Patient stratification and risk related treatment of NMIBC

Bladder cancer TURB

Prof. Paolo Gontero reviews risk stratification for Non-Muscle Invasive Bladder Cancer

Developments in perioperative immunotherapy for bladder and kidney cancers

Renal, bladder and prostate cancer guidelines 2021: From guidelines to real world

Practical management of bladder cancer

New treatments development in NMIBC

Time to Cystectomy: Patients' perspective

Is immune therapy changing the way we think about early bladder cancer?

EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

EAU Guidelines on Primary Urethral Carcinoma
